SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 5

Controversies in neonatology: The efficacy of inhaled nitric oxide in preterm infants with persistent pulmonary hypertension

Gonca VARDAR
Meliha AKSOY OKAN
Sevilay TOPÇUOĞLU
Nilgün KARADAĞ
Elif ÖZALKAYA
Hande OZGUN KARATEPE
Güner KARATEKİN
Pages
1303–1311
Publication Date
2022-09-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Material and Method: We retrospectively reviewed data of infants

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: There is limited and conflicting information in literature regarding use of inhaled nitric oxide (iNO) in preterm infants.
📊
Key Findings & Data:In this study we examined the characteristics of preterm infants with persistent pulmonary hypertension (PHT) who responded and did not respond to iNO therapy .
💡
Conclusion & Impact:Material and Method: We retrospectively reviewed data of infants
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Nitric oxide therapy · premature · pulmonary hypertension

Abstract

Introduction: There is limited and conflicting information in literature regarding use of inhaled nitric oxide (iNO) in preterm infants. In this study we examined the characteristics of preterm infants with persistent pulmonary hypertension (PHT) who responded and did not respond to iNO therapy . Material and Method: We retrospectively reviewed data of infants

🔖

Cite This Article

VARDAR, G., OKAN, M. A., TOPÇUOĞLU, S., KARADAĞ, N., ÖZALKAYA, E., KARATEPE, H. O., KARATEKİN, G. (2022). Controversies in neonatology: The efficacy of inhaled nitric oxide in preterm infants with persistent pulmonary hypertension. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 5, 1303–1311. https://ajindex.com/articles/776453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Myers TR. Therapeutic gases for neonatal and pediatric respiratory care. Respir Care 2003; 48: 399-422.
  2. Dani C, Pratesi S. Nitric oxide for the treatment of preterm infants with respiratory distress syndrome. Expert Opinion 2013; 14: 97-103.
  3. Shiraishi J, Kusuda S, Cho K, et al. Standardization of nitric oxide inhalation in extremely preterm infants in Japan. Pediatr Int 2019; 61: 152-7.
  4. Sasi A, Sehgal A. Use of inhaled nitric oxide in preterm infants: A regional survey of practices. Heart Lung 2014; 43: 347-50.
  5. Finer N, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2017; 1: CD000399. Nakwan N, Jain S, Kumar K, et al. An Asian multicentre retrospective study on pulmonary hypertension of the newborn: incidence, etiology, diagnosis, treatment and outcome. J Maternal Fetal Neonatal Med 2020; 33: 2032-7.
  6. Hoyle ES, Slee SL, Subhedar NV. Variation in the definition of pulmonary hypertension and clinical indications for the use of nitric oxide in neonatal clinical trials. Acta Paediatr 2020; 109: 930-4.
  7. Dani C, Corsini I, Cangemi J, Vangi V, Pratesi S. Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension. Pediatr Pulmonol 2017; 52: 1461-8.
  8. Rallis D, Deierl A, Atreja G, Chaban B, Banerjee J. The efficacy of inhaled nitric oxide treatment in premature infants with acute pulmonary hypertension. Early Hum Dev 2018; 127: 1-5.
  9. Kuba K, Bernstein PS.ACOG Practice Bulletin No. 188: Prelabor Rupture of Membranes. Obstet Gynecol 2018; 131: 1163-4.
  10. Ehrenkranz RA, Walsh MC, Vohr BR, et al. National Institutes of Child H, Human Development Neonatal Research N, Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-60.
  11. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529-34. International Committee for the Classification of Retinopathy of Prematurity, The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123: 991-9.
  12. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am1986; 33: 179-201.
  13. Liu K, Wang H, Yu SJ, Tu GW, Luo Z. Inhaled pulmonary vasodilators: a narrative review. Ann Transl Med 2021; 9: 597. Abman SH. Inhaled nitric oxide for the treatment of pulmonary a